Magellan Diagnostics - About the company
Magellan Diagnostics is an acquired company based in Billerica (United States), founded in 1968. It operates as a Blood lead testing solutions to identify and protect those at risk. Magellan Diagnostics has raised $34M in funding. The company has 4 active competitors, including 1 that has exited. Its top competitors include companies like Baseline Health, JT MeSh Diagnostics and Oligoscan.
Company Details
Blood lead testing solutions to identify and protect those at risk. The company innovates lab solutions focused on human biology and interactions, bringing high-quality lab results to the point of care. They are dedicated to offering reliable products that help identify individuals at risk of harm due to lead exposure. Committed to educating clinicians, policymakers, families, and communities about the permanent health damage caused by lead, and the importance of prevention and detection. They design and build analyzers for the measurement of lead in blood, creating portable instruments for use outside traditional laboratories, broadening the accessibility of lead testing. Their mission is to help identify and protect those at risk through high-quality, reliable products.
- Website
- www.magellandx.com/
Key Metrics
Founded Year
1968
Location
Billerica, United States
Stage
Acquired
Total Funding
$34M in 3 rounds
Latest Funding Round
Investors
Ranked
1st among 4 active competitors
Employee Count
3 as on Jul 31, 2026
Similar Companies
Exit Details
Acquired by Meridian Bioscience (Mar 24, 2016)
Magellan Diagnostics's acquisition details
Magellan Diagnostics got acquired by Meridian Bioscience on Mar 24, 2016 at an acquisition amount of $*****.
Click here to take a look at Magellan Diagnostics's acquisition in detail
Sign up to download Magellan Diagnostics' company profile
Magellan Diagnostics's funding and investors
Magellan Diagnostics has raised a total funding of $34M over 3 rounds. Its first funding round was on Mar 21, 2005. Its latest funding round was a Conventional Debt round on Nov 29, 2006 for $*****. 1 investor participated in its latest round. Magellan Diagnostics has 10 institutional investors.
Here is the list of recent funding rounds of Magellan Diagnostics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 29, 2006 | 4999889 | Conventional Debt | 6989392 | 9519370 | 2873021 | 4731591 |
Nov 29, 2006 | 4560321 | Series C | 3240518 | 4743808 | 6041061 | |
Mar 21, 2005 | 2852188 | Grant (prize money) | 7636057 | 7623399 | 5249331 |
View details of Magellan Diagnostics's funding rounds and investors
Magellan Diagnostics' founders and board of directors
Founder? Claim ProfileMagellan Diagnostics' employee count trend
Magellan Diagnostics has 3 employees as of Jul 26. Here is Magellan Diagnostics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Magellan Diagnostics's Competitors and alternates
Top competitors of Magellan Diagnostics include Baseline Health, JT MeSh Diagnostics and Oligoscan. Here is the list of Top 10 competitors of Magellan Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Magellan Diagnostics 1968, Billerica (United States), Acquired | Blood lead testing solutions to identify and protect those at risk | $34M | 42/100 | |
2nd | Baseline Health 2018, San Francisco (United States), Deadpooled | Provider of test kit for diagnosing body toxins | - | - | 24/100 |
3rd | JT MeSh Diagnostics 2019, Philadelphia (United States), Funding Raised | Developer of breakthrough diagnostics for radiation exposure and organ transplant viability | - | 22/100 | |
4th | Developer of diagnostic device for the screening of physiological imbalances | - | - | 16/100 | |
5th | Provider of a diagnostic test for heavy metal toxicity | - | - | 16/100 | |
6th | ![]() Beaufort Bar 2012, Burlington (United States), Deadpooled | Diagnostic tests for lead poisoning | - | - | 15/100 |
Looking for more details on Magellan Diagnostics's competitors? Click here to see the top ones
Magellan Diagnostics's Investments and acquisitions
Magellan Diagnostics has made no investments or acquisitions yet.
Reports related to Magellan Diagnostics
Here is the latest report on Magellan Diagnostics's sector:
News related to Magellan Diagnostics
•
Magellan Diagnostics Agrees to Plead Guilty, Pay $42 MillionFDA News•May 23, 2024•Magellan Diagnostics
•
•
Meridian Bioscience expands recall of LeadCare test kitsSeeking Alpha•Sep 02, 2021•Meridian Bioscience, Magellan Diagnostics
•
Magellan Diagnostics and PDXWildlife PartnerCitybizlist•Mar 16, 2017•Magellan Diagnostics, PDXWildlife
•
•
ESA Biosciences Awarded NIH Grant To Further Metabolomics Research | Business WireBusiness Wire•Mar 24, 2005•Magellan Diagnostics, NIH
•
•
The Pulse of the Global Healthcare CommunityHealthiosXchange•Magellan Diagnostics, NewStar Financial, Abingworth, kblvc.com and 5 others
•
Are you a Founder ?
FAQs about Magellan Diagnostics
Explore our recently published companies
- Captain - Montreal based, 2021 founded, Unfunded company
- Navigo - Delhi based, 2024 founded, Unfunded company
- Skynext - Mumbai based, 2020 founded, Unfunded company
- Digital Maker - Peterhead based, 2017 founded, Unfunded company
- Byteport - San Francisco based, 1999 founded, Seed company
- Back Benchers - India based, 2024 founded, Unfunded company
